Table 4 Univariate and multivariate Poisson regression with death for all-causes as the outcome

Gender

Male vs Female

1.55

(1.42-1.70)

1.24

(1.12-1.36)

Age at enrolment (years)

18-34

Ref.

Ref.

35-44

0.96

(0.88-1.06)

1.53

(1.36-1.71)

45-54

1.28

(1.12-1.47)

2.41

(2.05-2.83)

55-64

1.56

(1.27-1.92)

2.66

(2.13-3.33)

≥65

3.06

(2.24-4.19)

5.41

(3.89-7.52)

Year of enrolment

1986-1989

2.41

(1.99-2.91)

1.55

(1.25-1.94)

1990-1993

2.23

(1.84-2.70)

1.43

(1.15-1.78)

1994-1997

1.63

(1.34-1.98)

0.89

(0.71-1.10)

1998-2001

1.23

(1.00-1.51)

1.11

(0.90-1.36)

2002-2005

1.01

(0.81-1.27)

1.00

(0.80-1.26)

2006-2012

Ref.

Ref.

IDUs

Yes vs No

1.76

(1.62-1.90)

1.54

(1.40-1.70)

AIDS-event

Yes vs No

17.55

(16.22-18.99)

3.75

(3.43-4.11)

HBV/HCV co-infection

Yes vs No

0.95

(0.89-1.03)

CD4 cell count, cell/mm3

0-49

44.92

(37.90-53.25)

4.10

(3.62-4.65)

50-99

17.58

(14.48-21.33)

2.73

(2.36-3.16)

100-199

7.78

(6.45-9.39)

1.83

(1.62-2.08)

200-349

3.02

(2.45-3.67)

1.47

(1.31-1.65)

350-499

1.64

(1.32-2.04)

1.15

(1.01-1.30)

≥500

Ref.

Ref.

Antiretroviral therapy

cART

Ref.

Ref.

Subobtimal cART

3.26

(2.91-3.65)

2.18

(1.95-2.44)

No therapy

2.14

(1.96-2.33)

8.19

(7.23-9.27)

Cancer occurrence

Without cancer

Ref.

Ref.

ADC

14.60

(12.51-17.03)

1.22

(1.08-1.38)

NADC

10.48

(8.49-12.93)

1.29

(1.12-1.50)